Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.83B |
| 2 |
Roblox
RBLX
|
+$1.63B |
| 3 |
BILL Holdings
BILL
|
+$1.46B |
| 4 |
Airbnb
ABNB
|
+$774M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$620M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.32B |
| 2 |
Spotify
SPOT
|
+$1.39B |
| 3 |
Okta
OKTA
|
+$1.24B |
| 4 |
Alibaba
BABA
|
+$1.16B |
| 5 |
Amazon
AMZN
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 9.82% |
| 3 | Financials | 9.22% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Communication Services | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
SiTime
SITM
$20.6B
| $9.37M | ﹤0.01% |
45,904
-1,033
| -2% | -$184K |
|
2952
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.27B
| $9.37M | ﹤0.01% |
156,196
+28,531
| +22% | +$1.76M |
|
2953
RLJ Lodging Trust
RLJ
$1.81B
| $9.37M | ﹤0.01% |
630,355
-584,097
| -48% | -$8.39M |
|
2954
GH Research
GHRS
$2.1B
| $9.36M | ﹤0.01% |
424,260
+222,532
| +110% | +$4.53M |
|
2955
Bank OZK
OZK
$5.63B
| $9.35M | ﹤0.01% |
217,606
+17,036
| +8% | +$710K |
|
2956
Regal Rexnord
RRX
$11.9B
| $9.34M | ﹤0.01% |
62,131
-47,593
| -43% | -$6.83M |
|
|
TCVA
2957
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
| $9.31M | ﹤0.01% |
950,074
-5,514
| -0.6% | -$54.5K |
|
|
NVEE
2958
DELISTED
NV5 Global
NVEE
| $9.31M | ﹤0.01% |
377,732
+65,580
| +21% | +$1.62M |
|
2959
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.5B
| $9.3M | ﹤0.01% |
1,996,222
+348,757
| +21% | +$1.63M |
|
2960
ProShares Online Retail ETF
ONLN
$65.6M
| $9.29M | ﹤0.01% |
141,606
-22,015
| -13% | -$1.61M |
|
2961
Kirby Corp
KEX
$7.11B
| $9.29M | ﹤0.01% |
193,782
+124,913
| +181% | +$6.93M |
|
2962
Healthcare Services Group
HCSG
$1.51B
| $9.29M | ﹤0.01% |
371,844
+277,353
| +294% | +$7.5M |
|
|
GGN
2963
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$801M
| $9.28M | ﹤0.01% |
2,487,502
-9,560
| -0.4% | -$37K |
|
|
KNTE
2964
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $9.27M | ﹤0.01% |
402,875
+315,822
| +363% | +$6.88M |
|
2965
Ascendis Pharma A/S
ASND
$16.4B
| $9.27M | ﹤0.01% |
58,128
-20,222
| -26% | -$2.77M |
|
2966
Carpenter Technology
CRS
$27.7B
| $9.27M | ﹤0.01% |
282,993
-50,732
| -15% | -$1.8M |
|
|
UCB
2967
United Community Banks
UCB
$4.28B
| $9.25M | ﹤0.01% |
281,916
-40,017
| -12% | -$1.2M |
|
|
PML
2968
PIMCO Municipal Income Fund II
PML
$489M
| $9.25M | ﹤0.01% |
627,422
-56,965
| -8% | -$857K |
|
2969
AdvanSix
ASIX
$543M
| $9.24M | ﹤0.01% |
232,550
+18,195
| +8% | +$625K |
|
2970
Blink Charging
BLNK
$77.6M
| $9.24M | ﹤0.01% |
322,983
+34,175
| +12% | +$1.11M |
|
|
IHTA
2971
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
| $9.24M | ﹤0.01% |
938,077
+79,312
| +9% | +$780K |
|
|
ACB
2972
Aurora Cannabis
ACB
$185M
| $9.24M | ﹤0.01% |
133,496
+33,246
| +33% | +$2.36M |
|
2973
Travere Therapeutics
TVTX
$5.89B
| $9.24M | ﹤0.01% |
380,935
+243,852
| +178% | +$4.48M |
|
2974
Invesco S&P SmallCap Industrials ETF
PSCI
$195M
| $9.23M | ﹤0.01% |
101,667
-3,557
| -3% | -$327K |
|
2975
Methode Electronics
MEI
$585M
| $9.23M | ﹤0.01% |
219,503
+53,329
| +32% | +$2.45M |
|
Similar funds
Morgan Stanley's Q3 2021 Portfolio in Review
As of Q3 2021, Morgan Stanley held 8,301 positions worth $742B, down 2.1% from $758B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2021 filing shows 450 new, 3,451 increased, 3,331 reduced and 228 closed positions. Its largest new stake was Ginkgo Bioworks: 281,861 shares worth $131M. The largest sale was Alphabet (Google) Class C, an estimated $2.32B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2021 buy was Ginkgo Bioworks: 281,861 shares worth $131M.
- Morgan Stanley added most to Coupang in Q3 2021, an estimated $1.83B increase.
- Morgan Stanley's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.32B.
- Morgan Stanley fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $441M.
- Morgan Stanley's ten largest holdings make up 15% of its $742B portfolio in Q3 2021.
- Morgan Stanley opened 450 new positions and closed 228 in Q3 2021.
- Morgan Stanley's portfolio value fell 2.1% quarter-over-quarter to $742B.
Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.